Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma.
about
Melanoma: new insights and new therapiesPhase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.A phase 2 pilot trial of low-dose, continuous infusion, or "metronomic" paclitaxel and oral celecoxib in patients with metastatic melanomaA phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma.Targeting angiogenesis in melanoma: prospects for the futureMolecular-targeted therapy in malignant melanoma.Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.Metastatic melanoma: lactate dehydrogenase levels and CT imaging findings of tumor devascularization allow accurate prediction of survival in patients treated with bevacizumabMolecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond.Advances in the management of melanoma: targeted therapy, immunotherapy and future directions.Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.Targets, structures, and recent approaches in malignant melanoma chemotherapy.Current research and development of chemotherapeutic agents for melanomaMechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications.Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.Treatment of Brain Metastases.Targeting angiogenesis in melanoma
P2860
Q26853127-9945EC89-2BC4-4B01-AEC6-300D4058382EQ30424925-2E4687AE-B9EC-4350-9630-965E7C53BDE0Q33759537-7EDC2DF4-768B-4326-8C5D-95521B01FC72Q35050558-977B555B-9C57-49EF-9F11-2136DC7631F2Q35076316-82C81AD4-8C5A-4460-9EF3-7E746EE98651Q37483949-187235D2-5BA9-49D8-88C3-42B746349552Q37628695-11599007-FB83-4370-8EB7-875882308277Q37701127-78732278-DDAB-41E9-A83C-7D0D041A1635Q37778064-989FC807-2750-4F97-ACA8-ED99B4D56835Q38068205-1A813571-D460-46BD-8ED5-ADE92585E139Q38101607-49173141-BFC4-43CE-B68C-9CB7BCAD1A0FQ38129832-3E3C8A7F-A702-4CA9-B16A-294B761F572EQ38166569-F0A3A0C6-C311-4BFE-B668-06FDFA5E26A1Q38196881-EEC714CF-FAA2-4E39-AA86-458A85665F0DQ38748970-BAA7118C-7069-4ADC-90D9-0313ABFC8DB2Q53827061-04515BD8-32B0-4FA0-963C-4BA11A316EE9Q57569703-246B82B3-80E7-4EC3-9897-A5C002F7023C
P2860
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Preliminary results of the com ...... clitaxel in advanced melanoma.
@ast
Preliminary results of the com ...... clitaxel in advanced melanoma.
@en
type
label
Preliminary results of the com ...... clitaxel in advanced melanoma.
@ast
Preliminary results of the com ...... clitaxel in advanced melanoma.
@en
prefLabel
Preliminary results of the com ...... clitaxel in advanced melanoma.
@ast
Preliminary results of the com ...... clitaxel in advanced melanoma.
@en
P2093
P2860
P356
P1433
P1476
Preliminary results of the com ...... clitaxel in advanced melanoma.
@en
P2093
A Díaz-Lagares
A González
M González-Cao
S Martín-Algarra
P2860
P356
10.1159/000138351
P50
P577
2008-06-09T00:00:00Z